PFM
PCRX icon

Premier Fund Managers’s Pacira BioSciences PCRX Stock Holding History

Premier Fund Managers’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-6,769
Closed -$189K – 212
2024
Q2 		$189K Hold
6,769
– – 0.01% 190
2024
Q1 		$197K Sell
6,769
-117,764
-95% -$3.62M 0.01% 202
2023
Q4 		$4.18M Sell
124,533
-3,310
-3% -$96.8K 0.18% 87
2023
Q3 		$3.94M Sell
127,843
-23,434
-15% -$845K 0.19% 89
2023
Q2 		$5.98M Buy
+151,277
New +$6.25M 0.24% 78
2023
Q1 		– Sell
-46,971
Closed -$1.83M – 241
2022
Q4 		$1.83M Buy
46,971
+23,721
+102% +$1.15M 0.07% 144
2022
Q3 		$1.26M Sell
23,250
-141,000
-86% -$7.84M 0.09% 102
2022
Q2 		$9.63M Sell
164,250
-36,893
-18% -$2.42M 0.43% 66
2022
Q1 		$15.2M Buy
201,143
+25,450
+14% +$1.7M 0.53% 61
2021
Q4 		$10.7M Sell
175,693
-1,800
-1% -$99.3K 0.34% 81
2021
Q3 		$10.1M Hold
177,493
– – 0.33% 82
2021
Q2 		$10.8M Buy
177,493
+3,800
+2% +$241K 0.36% 72
2021
Q1 		$12.3M Sell
173,693
-30,637
-15% -$2.19M 0.48% 64
2020
Q4 		$12M Buy
204,330
+61,656
+43% +$3.61M 0.52% 59
2020
Q3 		$8.47M Buy
142,674
+91,074
+177% +$5.29M 0.49% 62
2020
Q2 		$2.71M Buy
+51,600
New +$2.16M 0.17% 116

Other funds holding PCRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
DPCM
Doma Perpetual Capital Management Miami, Florida $372M AUM 14.96% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Premier Fund Managers's PCRX Position: Q3 2024 in Review

Premier Fund Managers sold out of Pacira BioSciences (PCRX) in Q3 2024, closing a stake of 6,769 shares — an estimated $189K sold.

Premier Fund Managers first reported a position in PCRX in Q2 2020 and held it in 16 quarters. The position peaked at $15.2M in Q1 2022. 239 funds tracked by Wall St. Rank hold PCRX as of Q3 2024.

  • Premier Fund Managers reported no remaining Pacira BioSciences position as of Q3 2024 after selling out during the quarter.
  • Premier Fund Managers sold 6,769 Pacira BioSciences shares in Q3 2024, an estimated $189K.
  • Premier Fund Managers first reported a position in Pacira BioSciences in Q2 2020 and held it in 16 quarters.
  • Premier Fund Managers's Pacira BioSciences position peaked at $15.2M in Q1 2022.
  • 239 funds tracked by Wall St. Rank held Pacira BioSciences as of Q3 2024.

Based on Premier Fund Managers's 13F filing for Q3 2024, filed 8 Nov 2024.